Economists around the world expect muted U.S. economic growth in the coming quarters, and some indicators have shown an increased likelihood of a 2025 recession in recent weeks. [ Sign up for ...

A bipartisan, bicameral group of senators have introduced legislation that would give the president new authority to ...

Lebrikizumab is comparable or superior to many advanced systemic monotherapies for the short-term treatment of atopic dermatitis.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

In their own responses to the senators’ inquiries last fall, both Pfizer and Lilly emphasized the independence of their ...

Investors looking for safe havens in a dangerous market. China EV players, FedEx and Micron earnings next week.

Eli Lilly has raised its revenue guidance for 2024 by $3 billion, after reporting strong growth for tirzepatide in diabetes and obesity, fuelled by the end of supply constraints for starting doses.

Davoud Pourhossein, Global Director, Strategy and Innovation, Digital Workplace Solutions at Unisys shares strategies for digital transformation ...